Bio

Developing the next generation of psychedelic-inspired therapeutics for mental health indications at Mindstate Design Labs (Y Combinator S21 batch). You can learn more about psychedelic therapy here: Nature: How Ecstasy and Psilocybin are Shaking Up Psychiatry https://www.nature.com/articles/d41586-021-00187-9 New York Times: The Psychedelic Revolution is Coming. Psychiatry May Never Be the Same. https://www.nytimes.com/2021/05/09/health/psychedelics-mdma-psilocybin-molly-mental-health.html Wall Street Journal: How Psychedelic Drugs Are Making a Comeback to Treat Depression. https://www.wsj.com/podcasts/wsj-the-future-of-everything/how-psychedelic-drugs-are-making-a-comeback-to-treat-depression/e4d6a4ce-9b21-40c6-8741-91f97a53cd81 Previously I worked in venture investing and spinouts at UPMC Enterprises, the internal venture arm of UPMC. Prior to UPMC Enterprises I was a transaction-focused consultant, covering the full investment life cycle from angel and seed-stage startup funding rounds to Fortune 500 mergers, acquisitions, and divestitures.